Business & Industry
Business & Industry
Digital Health Tools Are Transforming Patient Care Models
The integration of advanced technology into the clinical environment is fundamentally altering the relationship between patients, providers, and the pharmaceutical industry. For decades, the standard approach to healthcare was reactive, centralized, and episodic. Patients would visit a hospital or...
Business & Industry
How GLP-1 Drugs Are Redefining Metabolic Disease Treatment
The pharmaceutical industry is currently witnessing a fundamental shift in how chronic conditions are managed, driven largely by the emergence of potent incretin therapies. While these treatments originally gained traction for their glucose lowering capabilities, the scope of their...
Business & Industry
Merck KGaA to Acquire Bio-Techne for $11.3 Billion to Bolster Life Science Division
The German pharmaceutical group Merck KGaA announced that it has entered into a definitive agreement to purchase the United States-based biotechnology firm Bio-Techne for $11.3 billion. This transaction represents the largest deal for the Darmstadt-based organization in more than...
Business & Industry
Novartis and Antares Therapeutics Form Strategic Partnership for Cancer Drug Development
Novartis has finalized a significant collaboration agreement with Antares Therapeutics to advance the discovery and development of small molecule therapies for various cancers. The deal, which could reach a total value of $1.9 billion, focuses on addressing oncology targets...
Business & Industry
Abu Dhabi and MSD Partner to Enhance Healthcare Access via New Logistics Hub
The Department of Health – Abu Dhabi (DoH) has announced a strategic collaboration with MSD to evaluate the feasibility of establishing an Abu Dhabi logistics hub. Located within the Health, Endurance, Longevity, and Medicine (HELM) Cluster, this planned facility...
Business & Industry
Bayer and Iambic Collaboration Expands AI Drug Discovery Efforts
Bayer has strengthened its pharmaceutical and ophthalmology portfolio through two separate transactions, completing the acquisition of Perfuse Therapeutics while also entering a collaboration agreement with Iambic Therapeutics. The moves provide Bayer with full ownership of Perfuse’s lead asset, PER-001,...
Business & Industry
Sanofi Partners with Pangaea for AI-Driven AATD Detection
Pangaea Data (Pangaea), a provider of a guideline-configured AI platform designed to help close care gaps and improve the identification of untreated and under-treated patients with difficult-to-diagnose conditions, has entered into a collaboration agreement with Sanofi. Under the arrangement,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read













